Pages that link to "Q419987"
Jump to navigation
Jump to search
The following pages link to hydralazine (Q419987):
Displaying 50 items.
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- arterial hypertension (Q41861) (← links)
- pulmonary hypertension (Q1128595) (← links)
- malignant hypertension (Q1641132) (← links)
- congestive heart failure (Q19000661) (← links)
- Hydralazine in infants with persistent hypoxemic respiratory failure (Q24200828) (← links)
- Hydralazine for essential hypertension (Q24235133) (← links)
- Hydralazine for pulmonary hypertension in low birth weight infants with chronic lung disease (Q24235616) (← links)
- Hydralazine for essential hypertension (Q24236445) (← links)
- Hydralazine for essential hypertension (Q24240813) (← links)
- Hydralazine for the management of essential hypertension (Q24247286) (← links)
- Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid (Q24288944) (← links)
- A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes (Q24804876) (← links)
- Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines (Q25255934) (← links)
- Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial (Q26822507) (← links)
- Metabolism of hydralazine by activated leukocytes: implications for hydralazine induced lupus (Q28237363) (← links)
- Metabolism of hydralazine: relevance to drug-induced lupus (Q28238389) (← links)
- Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance (Q28265046) (← links)
- Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases (Q28266597) (← links)
- An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia (Q28290358) (← links)
- Combination of isosorbide dinitrate and hydralazine in blacks with heart failure (Q28292266) (← links)
- Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial (Q28294892) (← links)
- Interference in Assays for Hydralazine in Humans by a Major Plasma Metabolite, Hydralazine Pyruvic Acid Hydrazone (Q28317103) (← links)
- Cardiotoxicity of hydralazine and minoxidil in the rat. Influence of age (Q28328179) (← links)
- Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone (Q28328590) (← links)
- Determination of unchanged hydralazine in plasma by gas-liquid chromatography using nitrogen-specific detection (Q28329535) (← links)
- Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates (Q28329681) (← links)
- Hypotension and Bradycardia Following Diazoxide and Hydralazine Therapy (Q28330350) (← links)
- Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension (Q28332357) (← links)
- Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism (Q28333271) (← links)
- A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine (Q28336064) (← links)
- Hydralazine and its metabolites: in vitro and in vivo activity in the rat (Q28336819) (← links)
- Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy (Q28339288) (← links)
- 3-Hydroxymethyl-s-triazolo[3,4-a]phthalazine, a novel urinary hydralazine metabolite in man (Q28339473) (← links)
- Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery (Q28361080) (← links)
- Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure (Q28361712) (← links)
- Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man. (Q28368036) (← links)
- DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells (Q28481440) (← links)
- Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat (Q30573749) (← links)
- Oxygenation and blood flow in tumors treated with hydralazine: evaluation with a novel luminescence-based fiber-optic sensor. (Q30860370) (← links)
- Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models (Q31925506) (← links)
- A cross-over study between hydrallazine and prazosin (Q33174014) (← links)
- Similar effects of nifedipine and hydralazine on anaesthesia and hypermotility induced by pentobarbitone in mice (Q33189739) (← links)
- The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours (Q33200054) (← links)
- Blood flow modification in the sccvii tumor: Effects of 5-Hydroxytryptamine, hydralazine, and propanolol (Q33278313) (← links)
- The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts (Q33544521) (← links)
- Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele (Q33556953) (← links)
- 4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives (Q33578718) (← links)
- Comparative electrophysiological effects of captopril or hydralazine combined with nitrate in patients with left ventricular dysfunction and inducible ventricular tachycardia (Q33611946) (← links)
- Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy (Q33690434) (← links)